Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: A retrospective study

Annals of Surgery

Volumn 234, Issue 5, 2001, Pages 689-696

  Philosophe, Benjamin ^a,b   Farney, Alan C ^a   Schweitzer, Eugene J ^a   Colonna, John O ^a   Jarrell, Bruce E ^a   Krishnamurthi, Venkatesh ^a   Wiland, Anne M ^a   Bartlett, Stephen T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PANCREAS TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

ADULT; ANASTOMOSIS, ROUX-EN-Y; ANASTOMOSIS, SURGICAL; DIABETES MELLITUS, TYPE 1; DUODENUM; FEMALE; GRAFT SURVIVAL; HUMANS; ILIAC VEIN; IMMUNOSUPPRESSIVE AGENTS; JEJUNUM; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PORTAL VEIN; RETROSPECTIVE STUDIES;

EID: 0034759013     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200111000-00016     Document Type: Article

References (32)

1. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy
2. Transplantation with urinary drainage of pancreatic secretions
3. Systemic venous drainage of pancreas allografts as independent causes of hyperinsulinemia in type I diabetic recipients
4. Significance of portal venous drainage after whole-organ pancreas transplantation for endocrine graft function and prevention of diabetic nephropathy
5. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidneypancreas transplantation
6. Differing effects of pancreas-kidney transplantation with systemic versus portal venous drainage on cholesteryl ester transfer in IDDM subjects
7. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
8. Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts
9. A technique for portal pancreatic transplantation with enteric drainage
10. Results of pancreas transplantation with portal venous and enteric drainage
11. Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition
12. Incidence of kidney and pancreas rejection following poral-enteric versus systemic-bladder pancreas-kidney transplantation
13. Simultaneous cadaver pancreas living donor kidney transplantation (SPLK): A new approach for the type I diabetic uremic patient
14. Evaluation of pancreas transplant needle biopsy
15. Isolated pancreas rejection in combined kidney-pancreas transplantation
16. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation
17. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats
18. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells
19. Enhanced survival of heterotopic rat heart allografts with portal venous drainage
20. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum
21. Role of the liver in kidney allograft rejection in the rat
22. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage
23. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival
24. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
25. Cross-presentation. A general mechanism for CTL immunity and tolerance
26. Are dendritic cells the key to liver transplant tolerance?
27. A role of nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigenspecific pretransplant immunization or transfusion
28. A role for γδTCR+ cells in regulation of rejection of small intestinal allografts in rats
29. Simultaneous liver and renal transplantation in man
30. Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitised patient
31. Chronic rejection in renal transplant recipients-risk factors and correlates